Institutional Ownership
Tvardi Therapeutics Inc
CUSIP 140755307COMTVRDQ1 2026
Institutional Holders
63
13F filers
Shares Held
2.27M
Aggregate institutional
Institutional Value
$7.23M
Q1 2026
Net New Holders
+2
13 new · 11 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions13
Increased19
Decreased16
Sold out11
Institutional Holders
63 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Slate Path Capital LP | 704.1K | $2.24M | 0 | Held |
| 2 | Blackrock, Inc. | 388.1K | $1.23M | −2.9K | Reduced |
| 3 | American Financial Group Inc | 223.7K | $711.2K | 0 | Held |
| 4 | Geode Capital Management, LLC | 182.3K | $580.0K | +25.2K | Added |
| 5 | Silvercrest Asset Management Group LLC | 101.0K | $321.3K | 0 | Held |
| 6 | State Street Corp | 97.2K | $309.2K | −18.3K | Reduced |
| 7 | Renaissance Technologies LLC | 92.1K | $292.9K | −12.4K | Reduced |
| 8 | Morgan Stanley | 72.9K | $231.8K | −11.6K | Reduced |
| 9 | Duncan Williams Asset Management, LLC | 63.2K | $201.1K | −17.5K | Reduced |
| 10 | Ubs Group AG | 50.5K | $160.4K | +14.9K | Added |
53 more institutional holders on Premium
See every fund holding Tvardi Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders